Development and validation of a high-performance liquid chromatography method using diode array detection for the simultaneous quantification of aripiprazole and dehydro-aripiprazole in human plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 867, Issue 1, 2008, Pages 15-19

  Lancelin, Frédérique ^a   Djebrani, Kayssa ^a   Tabaouti, Khalid ^a   Kraoul, Linda ^a   Brovedani, Sophie ^a   Paubel, Pascal ^a   Piketty, Marie Liesse ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

Aripiprazole; Dehydro aripiprazole; HPLC; Therapeutic drug monitoring

Indexed keywords

DRUG DELIVERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PATIENT MONITORING; PLASMA (HUMAN);

ARIPIPRAZOLE; DEHYDRO-ARIPIPRAZOLE; THERAPEUTIC DRUG MONITORING;

DRUG PRODUCTS;

ACETONITRILE; AMMONIA; ARIPIPRAZOLE;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIODE ARRAY DETECTION; FEMALE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID LIQUID EXTRACTION; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; VALIDATION STUDY;

ADOLESCENT; ADULT; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; QUINOLONES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 42749089623     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2008.02.026     Document Type: Article

References (14)

1. Gupta S., and Masand P. Ann. Clin. Psychiatry 16 (2004) 155
2. Stahl S.M. J. Clin. Psychiatry 62 (2001) 841
3. Lieberman J.A. CNS Drugs 18 (2004) 251
4. Jordan S., Koprivica V., Chen R., Tottori K., Kikuchi T., and Altar C.A. Eur. J. Pharmacol. 441 (2002) 137
5. Mallikaarjun S., Salazar D.E., and Bramer S.L. J. Clin. Pharmacol. 44 (2004) 179
6. Kubo M., Koue T., Inaba A., Takeda H., Maune H., Fukuda T., and Azuma J. Drug Metab. Pharmacokinet. 20 (2005) 55
7. Bristol-Myers squibb company/OtsuDk of America Pharmaceutical Inc. Abilify™ (aripiprazole) tablets prescribing information, Revised November 2006.
8. Baumann P., Hiemke C., Ulrich S., Gaertner I., Rao M.L., Eckermann G., Gerlach M., Kuss H.J., Laux G., Müller-Oerlinghausen B., Riederer P., and Zernig G. Ther. Drug Monit. 26 (2004) 167
9. Kubo M., Mizooku Y., Hirao Y., and Osumi T. J. Chromatogr. B 822 (2005) 294
10. Huang H.C., Liu C.H., Lan T.H., Hu T.M., Chiu H.J., Wu Y.C., and Tseng Y.L. J. Chromatogr. B. Anal. Technol. Biomed. Life Sci. 856 (2007) 57
11. Kirschbaum K.M., Müller M.J., Zernig G., Saria A., Mobascher A., Malevani J., and Hiemke C. Clin. Chem. 51 (2005) 1718
12. Shimokawa Y., Akiyama H., Kashiyama E., Koga T., and Miyamoto G. J. Chromatogr. B. Anal. Technol. Biomed. Life Sci. 821 (2005) 8
13. Center for Drug Evaluation and Research (FDA), Guidance for industry: Bioanalytical Method Validation, May 2001 (http://www.fda.gov/cder/guidance/4252fnl.pdf).
14. Molden E., Lunde H., Lunder N., and Refsum H. Ther. Drug Monit. 28 (2006) 744